Perform world-class research—advance our understanding of cancer genomics
Illumina next-generation sequencing (NGS) and microarray technologies represent the gold standard in quality worldwide—and account for ~90% of the world’s sequencing data.* Innovative, intuitive, and completely integrated, our sample-to-data solutions empower your lab to keep ahead of the curve in the rapidly evolving genomics revolution. So you’ll be better able to perform the world-class research you strive for—with the goal of uncovering new insights into the biology of cancer that can lead to meaningful advances in personalized medicine.
Our comprehensive product offerings support multiple cancer research applications, including studies of DNA, RNA, epigenetics, and more. Our range of sequencers can be scaled to meet your needs—from powerful, yet personal, benchtop models to versatile, high-throughput systems. With intuitive data analysis and management capabilities and unsurpassed customer support, we can deliver the answers you seek—quickly, accurately, and cost-effectively.
Cancer Genomics Research Topics
Explore genomics-based approaches to investigating cancer using NGS and microarrays.
- Cancer Sequencing Methods
- Cancer Immunotherapy Research
- Cancer Epigenetics
- Chromosomal Abnormalities
- Products and Services
- Resources
Cancer Sequencing Methods
NGS methods enable cancer researchers to perform whole-genome studies, targeted gene profiling, tumor-normal comparisons, and more. NGS also offers the sensitivity to detect rare somatic variants, tumor subclones, and circulating DNA fragments.
Cancer Immunotherapy Research
Immuno-oncology is an emerging field that has taken great strides in the fight against cancer, bolstered by a refined understanding of how tumors evade the natural immune response. Research into the mechanisms tumors use to inhibit the immune response have led to promising therapeutic targets.
Cancer Epigenetics
Changes in gene activation or gene silencing can impact the rate of cancer progression. Studying the epigenetic changes that influence gene expression can provide insight into important tumorigenic pathways.
Chromosomal Abnormalities
Genomic instability and chromosomal abnormalities are common features of cancer. Understanding these structural aberrations can inform studies of cancer etiology.
Products and Services
Illumina offers various NGS and microarray products and services to support cancer genomics research.
Resources
Learn more about Illumina technology and how it is being used in cancer research. Access publications, videos, webinars, and other educational resources.
Immune Profiling Identifies CD73 as a Combinatorial Target in Glioblastoma
Swetha Anandhan highlights the use of single cell RNA-sequencing to identify a unique population of macrophages in glioblastoma multiforme that persists after treatment with immune checkpoint inhibitors.
View Webinar
Related Cancer Genomics Research Articles
TruSight Oncology Family Grows with Liquid Biopsy and High-Throughput Assays
Providing customers with a versatile, scalable, sample-to-report workflow
Read Article
Using Genetic Testing to Advance Cancer Care
Australia-based XING Cancer Care is analyzing tumor DNA with the goal of improving cancer treatment.
Read Interview
The Weizmann Institute Uses NovaSeq to Drive Single Cell Research
By analyzing one cell at a time, Professor Amit is improving our understanding of biological systems in health and disease
Read ArticleThe NovaSeq 6000 System
High-quality, high-coverage sequencing offers a comprehensive view of the genome to detect variants accurately, characterize isoforms, and more. With increased throughput and reduced price per sample, the NovaSeq 6000 System is ideal for data-intensive applications.
View System
Featured Products
The Changing Landscape of NGS Implementation
NGS technology has accelerated the discovery of variants associated with cancer. Some of these research discoveries became the basis for companion diagnostics and laboratory developed tests (LDT) now in use in molecular diagnostic laboratories worldwide. We spoke with key opinion leaders about the ongoing challenges and potential of NGS in oncology testing.
Read Interview
Beginner's Guide to Next-Generation Sequencing
Considering bringing next-generation sequencing to your lab, but unsure where to start? These resources cover key topics in NGS and are designed to help you plan your first experiment.
Get Started
Learn More
Genomic Technologies for Cancer Research
Learn the numerous ways that genomic technologies can be applied to tumor biology.
Cancer Research Review
An overview of recent cancer genomics research publications featuring Illumina technology.
Interested in receiving newsletters, case studies, and information on cancer genomics?
Sign Up
Insights into Leukemia and Lymphoma
Munich Leukemia Laboratory is using NGS to gain a better understanding of leukemia and lymphoma subtypes and discover new therapeutic pathways.
Educational Webinars
Explore a variety of webinars on topics ranging from cancer research to NGS data analysis, microbiome studies, and more.
Methods Guide
All the information you need, from BeadChips to library preparation to sequencer selection and analysis. Select the best tools for your lab.
Sequencing Analysis of Tissue Samples: Fresh Frozen vs. FFPE
A researcher from Massachusetts General Hospital compares sequencing results from FFPE and fresh-frozen tumor samples.
References
*Data on file based on a 2013 study.